Clinical Trial Update: Zemaira Eosinophilic Esophagitis Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating Zemaira for eosinophilic esophagitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Zemaira (human alpha-1 proteinase inhibitor)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: RECRUITING